(Q34097597)

31 July 2017

title

The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma. (English)

1 reference

adaptive radiation therapy

31 July 2017

main subject

0 references

1 reference

Blasko JC

1

1 reference

31 July 2017

Grimm PD

series ordinal

2

1 reference

31 July 2017

Sylsvester JE

series ordinal

3

1 reference

31 July 2017

Cavanagh W

series ordinal

4

1 reference

31 July 2017

publication date

1 December 2000

1 reference

Radiotherapy and Oncology

31 July 2017

published in

1 reference

31 July 2017

volume

57

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

273-278

1 reference

Should brachytherapy be considered a therapeutic option in localized prostate cancer?

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900288-7

7 January 2021

5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900288-7

7 January 2021

103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900288-7

7 January 2021

Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900288-7

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900288-7

7 January 2021

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900288-7

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900288-7

7 January 2021

10.1016/S0167-8140(00)00288-7

Identifiers

DOI

1 reference

31 July 2017

1 reference